Use of IL-20 antagonists for alleviating spinal cord injury

摘要

Alleviating neural injury, such as spinal cord injury, in a subject (e.g., a human subject) in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

主权项

1. A method for alleviating a neural injury in a subject, comprising administering to a subject in need thereof an effective amount of an IL-20 antagonist, wherein the neural injury is spinal cord injury (SCI), and wherein the IL-20 antagonist is an antibody that binds IL-20 or an antibody that binds an IL-20 receptor.